From standard treatment to personalized medicine: role of IDH1 mutations in low-grade glioma evolution and treatment

World Neurosurg. 2010 Apr;73(4):234-6. doi: 10.1016/j.wneu.2010.02.050.
No abstract available

Publication types

  • News

MeSH terms

  • Brain Neoplasms / enzymology*
  • Brain Neoplasms / etiology
  • Brain Neoplasms / genetics
  • Brain Neoplasms / therapy*
  • Genetic Predisposition to Disease / genetics*
  • Glioma / enzymology*
  • Glioma / etiology
  • Glioma / genetics
  • Glioma / therapy*
  • Humans
  • Isocitrate Dehydrogenase / genetics*
  • Mutation / genetics*
  • Precision Medicine / methods
  • Precision Medicine / trends*

Substances

  • Isocitrate Dehydrogenase
  • IDH1 protein, human